Cullinan Oncology Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $19.68 on 02/12/24 and the lowest value was $7.64 on 12/12/23.
52-week price history of CGEM Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cullinan Oncology Inc’s current trading price is -16.92% away from its 52-week high, while its distance from the 52-week low is 114.01%. The stock’s price range during this period has spanned from $7.64 to $19.68. In the Healthcare sector, the Cullinan Oncology Inc’s shares surpassed a trading volume of approximately 0.65 million for the day, which was noticeably higher compared to the average daily volume of 9.0.38 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Cullinan Oncology Inc (CGEM) has experienced a quarterly rise of 93.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 699.45M and boasts a workforce of 62 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.76, with a change in price of +7.63. Similarly, Cullinan Oncology Inc recorded 295,638 in trading volume during the last 100 days, posting a change of +87.50%.
Examining CGEM’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CGEM stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
CGEM Stock Stochastic Average
Today, Cullinan Oncology Inc’s raw stochastic average for the past 50 days stands at 68.10%, indicating a rise from the raw stochastic average of the last 20 days, which was 8.01%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 28.08% and 40.97% respectively.
CGEM Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 60.45%.However, over the last six months, we can see a weaker performance of 47.30%. Over the last 30 days, the price of CGEM has leaped by -11.48%. And in the last five days, it has fallen by -11.48%.
